HSD10 disease is characterized by progressive neurodegeneration and includes intellectual disability, language defects, bradykinesia, ataxia, epilepsy, visual and auditory disorders, hypotonia, cardiomyopathy and metabolic disorders. The gene discussed is FSIP1; the disease is metabolic disease.